These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37111679)

  • 21. Orofacial pain management: current perspectives.
    Romero-Reyes M; Uyanik JM
    J Pain Res; 2014; 7():99-115. PubMed ID: 24591846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orofacial symptoms related to temporomandibular joint arthritis in juvenile idiopathic arthritis: smallest detectable difference in self-reported pain intensity.
    Stoustrup P; Kristensen KD; Verna C; Küseler A; Herlin T; Pedersen TK
    J Rheumatol; 2012 Dec; 39(12):2352-8. PubMed ID: 23027886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic Pain and Overview or Differential Diagnoses of Non-odontogenic Orofacial Pain.
    Renton T
    Prim Dent J; 2019 Feb; 7(4):71-86. PubMed ID: 30835670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy.
    Post JM; Loch S; Lerner R; Remmers F; Lomazzo E; Lutz B; Bindila L
    Front Mol Neurosci; 2018; 11():67. PubMed ID: 29593494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plastic changes in nociceptive pathways contributing to persistent orofacial pain.
    Shinoda M; Hitomi S; Iwata K; Hayashi Y
    J Oral Biosci; 2022 Sep; 64(3):263-270. PubMed ID: 35840073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic facial pain: different comorbidities and characteristics between neuropathic and nonneuropathic conditions.
    Puerta MY; Galhardoni R; Teixeira MJ; de Siqueira JTT; de Siqueira SRDT
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Sep; 130(3):273-282. PubMed ID: 32561251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of oro-facial pain conditions on oral health-related quality of life: A systematic review.
    Oghli I; List T; Su N; Häggman-Henrikson B
    J Oral Rehabil; 2020 Aug; 47(8):1052-1064. PubMed ID: 32415993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-nociceptive effects of ECa 233 a standardized extract of Centella asiatica (L.) Urban on chronic neuropathic orofacial pain in mice.
    Buapratoom A; Wanasuntronwong A; Khongsombat O; Tantisira MH
    J Ethnopharmacol; 2022 Jan; 283():114737. PubMed ID: 34648902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
    Kaur S; White S; Bartold M
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canadian Orofacial Pain Team workshop report on the global year against orofacial pain.
    Lavigne GJ; Sessle BJ
    Pain Res Manag; 2015; 20(1):7-14. PubMed ID: 25522352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: Role of CGRP in orofacial pain.
    Romero-Reyes M; Pardi V; Akerman S
    Exp Neurol; 2015 Sep; 271():95-103. PubMed ID: 25981890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental Methods to Inform Diagnostic Approaches for Painful TMJ Osteoarthritis.
    Sperry MM; Kartha S; Winkelstein BA; Granquist EJ
    J Dent Res; 2019 Apr; 98(4):388-397. PubMed ID: 30819041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revolutionizing orofacial pain management: the promising potential of stem cell therapy.
    Ren K; Vickers R; Murillo J; Ruparel NB
    Front Pain Res (Lausanne); 2023; 4():1239633. PubMed ID: 38028430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Position paper: appropriate use of pharmacotherapeutic agents by the orofacial pain dentist.
    Heir GM; Haddox JD; Crandall J; Eliav E; Radford S; Schwartz A; Jaeger B; Ganzberg S; Aquino C; Benoliel R;
    J Orofac Pain; 2011; 25(4):381-90. PubMed ID: 22329011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orofacial and general disorders in oral medicine patients. Oral and medical history.
    Lundström IM
    Swed Dent J; 2009; 33(1):27-39. PubMed ID: 19522315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of pharmacy in the management of patients with temporomandibular disorders and orofacial pain.
    Brazeau GA; Gremillion HA; Widmer CG; Mahan PE; Benson MB; Mauderli AP; Riley JL; Smith CL
    J Am Pharm Assoc (Wash); 1998; 38(3):354-61; quiz 362-3. PubMed ID: 9654866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporomandibular disorders, head and orofacial pain: cervical spine considerations.
    Kraus S
    Dent Clin North Am; 2007 Jan; 51(1):161-93, vii. PubMed ID: 17185065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (-)-α-Bisabolol reduces orofacial nociceptive behavior in rodents.
    Melo LT; Duailibe MA; Pessoa LM; da Costa FN; Vieira-Neto AE; de Vasconcellos Abdon AP; Campos AR
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):187-195. PubMed ID: 27900410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporomandibular joint steroid injections in patients with juvenile idiopathic arthritis: an observational pilot study on the long-term effect on signs and symptoms.
    Stoustrup P; Kristensen KD; Küseler A; Pedersen TK; Herlin T
    Pediatr Rheumatol Online J; 2015 Dec; 13():62. PubMed ID: 26689191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats.
    Seol TK; Lee W; Park S; Kim KN; Kim TY; Oh YN; Jun JH
    Korean J Anesthesiol; 2017 Oct; 70(5):561-566. PubMed ID: 29046777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.